Filgrastim biosimilar (Bio-Ker)

非格司亭生物类似药（Bio-Ker）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFilgrastim biosimilar (Bio-Ker)

Drug Alias NameBK-0023

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar

Mechanisms of ActionColony stimulating factor 3 receptor agonists

TargetsColony stimulating factor 3 receptor

Therapy Area/IndicationsNeutropenia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySwitzerland

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaN/A

Originator CompaniesBio-Ker Srl

China Registration ClassN/A

Active CompaniesBio-Ker Srl

Inactive CompaniesN/A

Active IndicationsNeutropenia

Inactive IndicationsN/A

ATC CodeL03AA02